Calamatta Cuschieri Moneybase plc on Tuesday announced the resignation of Mark Decesare as Group Chief Financial Officer, effective from 1st November 2024.
Mr Decesare was appointed back in December 2020, having previously held the position of Senior Finance Director at Alvogen, a global pharmaceutical company.
According to Mr Decesare’s LinkedIn, he is making a return to the pharma sector, and has taken on a new position CFO of a Malta-based pharma company called Adalvo.
In Calamatta Cuschieri’s announcement, the company confirmed that it is in the process of recruiting a replacement. In the interim, “the company has more than adequate resources in the finance department to meet its ongoing obligations”.
James Barbara brought a group of major businesses together under a new corporate identity.
His appointment follows the departure of Jonathan Camilleri as CEO.
Joining an established family business brings a different challenge to building one from the ground up. The foundations already exist, ...
Quantum tech firm iQrypto is set to expand its operations to Malta.